1. Turner, T. Proton pump inhibitors. Drugwatch
https://www.drugwatch.com/proton-pump-inhibitors/
(2017).
2. Statista. Top 20 pharmaceutical products by sales worldwide in 2014 (in billions US dollars). Statista
https://www.statista.com/statistics/258022/top-10-pharmaceutical-products-by-global-sales-2011/
(2017).
3. Lessell, S. Omeprazole (correction of omepraxole) and ocular damage. Concerns on safety of drug are unwarranted. BMJ 316, 7124–7167 (1998).
4. Stolte, M., Bethke, B., Rühl, G. & Ritter, M. Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z. Gastroenterol. 30, 134–138 (1992).
5. Fiocca, R. et al. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial. Aliment. Pharmacol. Ther. 36, 959–971 (2012). A controlled study on the long-term effect of PPIs on endocrine and exocrine gastric cells.